Skip to main content

Table 1 Baseline and demographic characteristics of lean and obese cohorts

From: Insulin resistance induced by de novo pathway–generated C16-ceramide is associated with type 2 diabetes in an obese population

Parameters

Lean

Obese

P Value

N = 20

 N = 98

Mean ± SD

Mean ± SD

Age (years)

36.19 ± 9.83

35.13 ± 9.83

0.508

Sex (M : F)

1 : 1.9

1 : 2.5

 

BMI (kg/m2)

24.66 ± 3.24

45.59 ± 8.25

< 0.005*

Waist circ. (cm)

72.64 ± 17.26

130.99 ± 12.72

< 0.005*

Hip circ. (cm)

96.05 ± 5.55

131.41 ± 10.01

< 0.005*

Cholesterol (mg/dL)

185.02 ± 73.24

187.69 ± 39.13

0.815

Triglycerides (mg/dL)

118.12 ± 80.97

117.09 ± 75.15

0.956

HDL (mg/dL)

50.35 ± 14.15

46.56 ± 13.85

0.269

LDL (mg/dL)

112.69 ± 57.20

121.92 ± 31.99

0.315

FBS (mg/dL)

94.67 ± 9.62

119.70 ± 39.30

0.006*

Insulin (mcIU/mL)

8.84 ± 2.97

17.89 ± 10.65

< 0.005*

HOMA-IR

2.09 ± 0.81

5.31 ± 3.63

< 0.005*

Albumin (g/L)

3.71 ± 0.46

3.51 ± 0.40

0.052

T-protein (g/L)

7.08 ± 0.55

7.28 ± 0.49

0.115

T-bilirubin (µmol/L)

0.55 ± 0.35

0.47 ± 0.37

0.417

LDH (IU/L)

175.80 ± 54.66

197.37 ± 50.91

0.0913

AST (IU/L)

29.35 ± 23.31

32.25 ± 31.66

0.699

ALT (IU/L)

66.60 ± 89.65

47.75 ± 44.54

0.162

ALP (IU/L)

72.35 ± 32.08

83.63 ± 27.93

0.111

GGT (IU/L)

56.35 ± 47.75

44.50 ± 32.01

0.171

PT (IU/L)

12.32 ± 0.78

12.24 ± 0.87

0.688

TSH (mIU/L)

1.46 ± 0.92

2.06 ± 1.17

0.038*

  1. *P< 0.05